Animoca Brands subsidiary SPORTPASS lands a slam dunk with Euroleague Basketball digital collab
Next-gen fan engagement and gaming platform SPORTPASS teams up with Euroleague Basketball Partnership aimed at bringing a whole new level of excitement in the digital [more…]
Anson turns the tap on a potential maiden lithium brine resource
Anson starts resource drilling at the Green River lithium brine project in Utah First hole to reach as deep as ~3,292m to sample the Mississippian [more…]
Q+A: What are SPAC vehicles, how do they work, and why Jett Capital Advisors reckon EUR’s Wolfsberg asset could unlock huge value on the NASDAQ
If you’re an active investor, there’s a good chance SPACS – or special purpose acquisition companies – have popped up on your radar. An easy [more…]
Power Up: Australia’s rooftop solar boom is missing a key ingredient
Rooftop solar has been the real engine of renewable energy growth – accounting for more than a quarter of total Australia renewable energy growth in [more…]
Buying a House After 60: What You Need to Know
Many might wonder if age becomes a barrier when purchasing a home in your 60s or beyond. Buying a house at this stage of life [more…]
THE SECRET CELLAR: Your country needs you… to buy these extra-special reds at extra-special prices
Hopes are soaring that China will lift its punishing tariffs on Australian wine within weeks, enabling winemakers to start rebuilding after four years of pain. [more…]
Xbox, Nintendo, or PlayStation: The Shifting Sands of Video Game Exclusivity
In a landmark announcement that may herald a significant shift in the gaming industry’s future, Microsoft’s Phil Spencer revealed that four of the company’s Xbox [more…]
Ex-dividend date: Why should you care and how it can affect your stock’s price
It’s the half year season, which means dividend time for investors What is ex-dividend and why should you care? Can you make profits out of [more…]
These ASX biotechs want to tackle cancer head-on for better outcomes
Early detection and effective treatment can lead to remission or cure for many cancers Optiscan’s tech brings surgeons and pathologists together to better diagnose, treat [more…]
Long Shortz with RareX: Hunting new game in a changing market
Stockhead’s Ashtyn Hiron sits down with RareX (ASX:REE) CEO of RareX Jame Durant to get the short end of the long story on the company’s [more…]